386 related articles for article (PubMed ID: 3052050)
1. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.
Blumberg A; Weidmann P; Shaw S; Gnädinger M
Am J Med; 1988 Oct; 85(4):507-12. PubMed ID: 3052050
[TBL] [Abstract][Full Text] [Related]
2. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients.
Kim HJ
Nephron; 1996; 72(3):476-82. PubMed ID: 8852501
[TBL] [Abstract][Full Text] [Related]
3. Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure.
Blumberg A; Weidmann P; Ferrari P
Kidney Int; 1992 Feb; 41(2):369-74. PubMed ID: 1552710
[TBL] [Abstract][Full Text] [Related]
4. Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia.
Allon M; Takeshian A; Shanklin N
Kidney Int; 1993 Jan; 43(1):212-7. PubMed ID: 8433561
[TBL] [Abstract][Full Text] [Related]
5. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.
Allon M; Shanklin N
Am J Kidney Dis; 1996 Oct; 28(4):508-14. PubMed ID: 8840939
[TBL] [Abstract][Full Text] [Related]
6. Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis.
Furuya R; Kumagai H; Sakao T; Maruyama Y; Hishida A
Nephron; 2002; 92(3):576-81. PubMed ID: 12372940
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches.
Ngugi NN; McLigeyo SO; Kayima JK
East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416
[TBL] [Abstract][Full Text] [Related]
8. Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure.
Conte G; Dal Canton A; Imperatore P; De Nicola L; Gigliotti G; Pisanti N; Memoli B; Fuiano G; Esposito C; Andreucci VE
Kidney Int; 1990 Aug; 38(2):301-7. PubMed ID: 2402122
[TBL] [Abstract][Full Text] [Related]
9. Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
Montoliu J; Lens XM; Revert L
Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459
[TBL] [Abstract][Full Text] [Related]
10. Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease.
Allon M; Dansby L; Shanklin N
Am J Med; 1993 May; 94(5):475-482. PubMed ID: 8498392
[TBL] [Abstract][Full Text] [Related]
11. Correction of hyperkalemia by bicarbonate despite constant blood pH.
Fraley DS; Adler S
Kidney Int; 1977 Nov; 12(5):354-60. PubMed ID: 24132
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral glucose administration on serum potassium concentration in hemodialysis patients.
Muto S; Sebata K; Watanabe H; Shoji F; Yamamoto Y; Ohashi M; Yamada T; Matsumoto H; Mukouyama T; Yonekura T; Namiki S; Kusano E
Am J Kidney Dis; 2005 Oct; 46(4):697-705. PubMed ID: 16183425
[TBL] [Abstract][Full Text] [Related]
13. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients.
Allon M; Copkney C
Kidney Int; 1990 Nov; 38(5):869-72. PubMed ID: 2266671
[TBL] [Abstract][Full Text] [Related]
14. Response of plasma aldosterone to sequential ultrafiltration, dialysis and conventional hemodialysis.
Farinelli A; Squerzanti R; De Paoli Vitali E; Bagni B; Cavallini AR; Gilli P; Bedani PL
Nephron; 1980; 26(6):274-9. PubMed ID: 7005702
[TBL] [Abstract][Full Text] [Related]
15. Glucose-induced paradoxical hyperkalemia in patients with suppression of the renin-aldosterone system: prevention by sodium depletion.
Radó JP
J Endocrinol Invest; 1979; 2(4):401-6. PubMed ID: 395185
[TBL] [Abstract][Full Text] [Related]
16. Influence of the alpha-1-adrenergic receptor blocker doxazosin on exercise-induced hyperkalemia in hemodialysis patients.
Nowicki M; Waluś T; Kokot F
Kidney Blood Press Res; 2002; 25(1):55-60. PubMed ID: 11834878
[TBL] [Abstract][Full Text] [Related]
17. Effect of erythropoietin treatment on blood pressure and intracellular cation concentrations in maintenance hemodialysis patients.
Okura Y; Oshima T; Yasunobu Y; Amano K; Mori M; Shinozaki K; Kajiyama G
Hypertens Res; 1996 Jun; 19(2):91-5. PubMed ID: 10968201
[TBL] [Abstract][Full Text] [Related]
18. [The regulation of plasma aldosterone in hemodialysis patients].
Louis F; Zwahlen A; Favre H; Vallotton M
Schweiz Med Wochenschr; 1980 Dec; 110(49):1882-4. PubMed ID: 7006078
[TBL] [Abstract][Full Text] [Related]
19. Control of plasma aldosterone during hemodialysis in patients with terminal renal failure.
Vetter W; Záruba K; Armbruster H; Beckerhoff R; Nussberger J; Furrer J; Fontana A; Siegenthaler W
Nephron; 1977; 18(2):114-23. PubMed ID: 857174
[TBL] [Abstract][Full Text] [Related]
20. [Primary hypoaldosteronism and secondary pseudo-hypoaldosteronism].
Klaus D; Lederle RM; Vecsei P
Klin Wochenschr; 1984 Aug; 62(16):753-8. PubMed ID: 6090761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
